Stock Track | agilon health Plunges 16% After-Hours on Weak Q4 Earnings and Outlook

Stock Track

02-26

agilon health, inc. (AGL) stock plummeted 15.98% in the after-hours trading session on Tuesday, following the company's disappointing fourth quarter 2024 earnings results and weak guidance for the upcoming fiscal year.

The healthcare services company specializing in senior care reported adjusted earnings per share of -$0.26 for Q4 2024, missing analyst estimates of -$0.23 per share. Revenue rose 44.2% year-over-year to $1.52 billion, in line with expectations. However, agilon health's adjusted EBITDA of -$83.97 million significantly lagged the consensus estimate of -$69.92 million.

More concerning was agilon health's outlook for fiscal 2025. The company guided for revenue growth of just -2.2% year-over-year at the midpoint of its range, a sharp deceleration from the 40.7% growth achieved in fiscal 2024. agilon health's projected 2025 EBITDA guidance of -$75 million also fell short of analyst expectations, highlighting continued profitability challenges amid a "challenging Medicare Advantage environment."

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1196685982"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1196685982\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1196685982?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-26 06:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196685982","market":"hk","top_or_hot":-1,"title":"Stock Track | agilon health Plunges 16% After-Hours on Weak Q4 Earnings and Outlook","media":"Stock Track","content":"<html><body><p>agilon health, inc. (AGL) stock plummeted 15.98% in the after-hours trading session on Tuesday, following the company's disappointing fourth quarter 2024 earnings results and weak guidance for the upcoming fiscal year.</p>\n<p>The healthcare services company specializing in senior care reported adjusted earnings per share of -$0.26 for Q4 2024, missing analyst estimates of -$0.23 per share. Revenue rose 44.2% year-over-year to $1.52 billion, in line with expectations. However, agilon health's adjusted EBITDA of -$83.97 million significantly lagged the consensus estimate of -$69.92 million.</p>\n<p>More concerning was agilon health's outlook for fiscal 2025. The company guided for revenue growth of just -2.2% year-over-year at the midpoint of its range, a sharp deceleration from the 40.7% growth achieved in fiscal 2024. agilon health's projected 2025 EBITDA guidance of -$75 million also fell short of analyst expectations, highlighting continued profitability challenges amid a \"challenging Medicare Advantage environment.\"</p></body></html>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Stock Track | agilon health Plunges 16% After-Hours on Weak Q4 Earnings and Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | agilon health Plunges 16% After-Hours on Weak Q4 Earnings and Outlook\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-02-26 06:04</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>agilon health, inc. (AGL) stock plummeted 15.98% in the after-hours trading session on Tuesday, following the company's disappointing fourth quarter 2024 earnings results and weak guidance for the upcoming fiscal year.</p>\n<p>The healthcare services company specializing in senior care reported adjusted earnings per share of -$0.26 for Q4 2024, missing analyst estimates of -$0.23 per share. Revenue rose 44.2% year-over-year to $1.52 billion, in line with expectations. However, agilon health's adjusted EBITDA of -$83.97 million significantly lagged the consensus estimate of -$69.92 million.</p>\n<p>More concerning was agilon health's outlook for fiscal 2025. The company guided for revenue growth of just -2.2% year-over-year at the midpoint of its range, a sharp deceleration from the 40.7% growth achieved in fiscal 2024. agilon health's projected 2025 EBITDA guidance of -$75 million also fell short of analyst expectations, highlighting continued profitability challenges amid a \"challenging Medicare Advantage environment.\"</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AGL","symbol_name":"agilon health, inc.","start_time":0,"source_url":"","article_id":"1196685982","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196685982","pubTimestamp":1740521092,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"agilon health, inc.  stock plummeted 15.98% in the after-hours trading session on Tuesday, following the company's disappointing fourth quarter 2024 earnings results and weak guidance for the upcoming fiscal year.The healthcare services company specializing in senior care reported adjusted earnings per share of -$0.26 for Q4 2024, missing analyst estimates of -$0.23 per share. Revenue rose 44.2% year-over-year to $1.52 billion, in line with expectations. However, agilon health's adjusted EBITDA ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AGL":"agilon health, inc."},"translate_title":"由于第四季度盈利和前景疲软，agilon health盘后暴跌16%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AGL":1},"content_text":"agilon health, inc. (AGL) stock plummeted 15.98% in the after-hours trading session on Tuesday, following the company's disappointing fourth quarter 2024 earnings results and weak guidance for the upcoming fiscal year.\nThe healthcare services company specializing in senior care reported adjusted earnings per share of -$0.26 for Q4 2024, missing analyst estimates of -$0.23 per share. Revenue rose 44.2% year-over-year to $1.52 billion, in line with expectations. However, agilon health's adjusted EBITDA of -$83.97 million significantly lagged the consensus estimate of -$69.92 million.\nMore concerning was agilon health's outlook for fiscal 2025. The company guided for revenue growth of just -2.2% year-over-year at the midpoint of its range, a sharp deceleration from the 40.7% growth achieved in fiscal 2024. agilon health's projected 2025 EBITDA guidance of -$75 million also fell short of analyst expectations, highlighting continued profitability challenges amid a \"challenging Medicare Advantage environment.\"","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1}}}